Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Head and Neck Neoplasms 3 Nasopharyngeal Carcinoma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hematologic Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Plasmacytoma 1 Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hypopharyngeal Neoplasms 1 Hodgkin Disease 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Gastric Cancer 1 Adenocarcinoma of Lung 1

Interventions

Paclitaxel 9 apatinib 8 Capecitabine 7 Oxaliplatin 6 Cisplatin 5 camrelizumab 4 S 1 (combination) 4 Fluorouracil 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 titanium silicide 2 Leucovorin 2 vorolanib 1 trifluridine tipiracil drug combination 1 tipiracil 1 spartalizumab 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 lobaplatin 1 linrodostat 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 Trifluridine 1 Sunitinib 1 SHR-1701 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Gastric Cancer × CF regimen × Clear all

NCT00992199 2010-09-08

IPchemo-AGC

Fudan University

Phase 2 Unknown

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡